Variable benefit in neuropsychological function in HIV-infected HAART-treated patients

Neurology

Volumn 66, Issue 9, 2006, Pages 1447-1450

  Cysique, Lucette A J ^a,d   Maruff, Paul ^b   Brew, Bruce J ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d HNRC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA;

ADULT; ANXIETY; ARTICLE; ATTENTION; BRAIN FUNCTION; CD4 LYMPHOCYTE COUNT; COGNITION; DEPRESSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; LEARNING; MAJOR CLINICAL STUDY; MEMORY; MOTOR COORDINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SELF REPORT; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATTENTION; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE; SAMPLING STUDIES; VERBAL LEARNING; VIRAL LOAD;

EID: 33646703373     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000210477.63851.d3     Document Type: Article

References (10)

1. Dore GJ, McDonald A, Li Y, Kaldo JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003;17:1539-1545.
2. Tozzi V, Balestra P, Galgani S, et al. Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr 2001;28:19-27.
3. Sacktor N, McDermott M, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002;8:136-142.
4. Cysique L, Maruff P, Brew B. Prevalence and pattern of neuropsychological impairment in HIV/AIDS-infection across pre and post-highly active antiretroviral therapy eras: a combined study of 2 cohorts. J Neurovirol 2004;10:350-357.
5. Mollica C, Maruff P, Vance A. Development of a statistical approach to classifying treatment response in individual children with ADHD. Hum Psychopharmacol 2004;19:445-456.
6. Ingraham L, Aiken C. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996;10:120-124.
7. Bland J, Altman D. Calculating correlation coefficients with repeated observations: part 1 - correlation within subjects. BMJ 1995;310:446.
8. Cysique L, Maruff P, Brew B. Antiretroviral therapy in HIV infection: are neurologically active drugs important? Arch Neurol 2004;61:1699-1704.
9. Rabbitt P, Diggle P, Holland F, McInnes L. Practice and drop-out effects during a 17-year longitudinal study of cognitive aging. J Gerontol B Psychol Sci Soc Sci 2004;59B:84-97.
10. Gonzalez E, Rovin B, Sen L, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 2002;99:13795-13800.